Le Lézard
Classified in: Health, Science and technology

Cellectis S.A. Reports Results from Combined Shareholders Meeting Held on June 25, 2019


Regulatory News:

Cellectis S.A. held its Combined Shareholders Meeting (Euronext Growth: ALCLS; Nasdaq: CLLS) on June 25, 2019 at its head office in Paris.

At the meeting, during which more than 68% of voting rights were exercised, Resolutions 1 through 18, 23 and 24 were adopted. Resolutions 19 through 22 and Resolution 25 were rejected. The detailed results of the vote and the resolutions are available on the company's website www.cellectis.com/en/investors/general-meetings/.

About Cellectis

Cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited T-cells (UCART). By capitalizing on its 19 years of expertise in gene editing ? built on its flagship TALEN® technology and pioneering electroporation system PulseAgile ? Cellectis uses the power of the immune system to target and eradicate cancer cells.

Using its life-science-focused, pioneering genome engineering technologies, Cellectis' goal is to create innovative products in multiple fields and with various target markets.

Cellectis is listed on the Nasdaq market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find out more about us, visit our website: www.cellectis.com

Talking about gene editing? We do it. TALEN® is a registered trademark owned by Cellectis.


These press releases may also interest you

at 17:34
Payfare Announces Unaudited Fourth Quarter and Full Year 2023 Financial Results
Payfare Inc. ("Payfare" or the "Company") , a leading fintech powering instant payout and digital banking solutions for workforces, today announced summarized unaudited results for the fourth quarter and year ending December 31, 2023. Unaudited Q4...

at 17:33
A new era in intelligent workplace management: Neowrk receives R$ 10 million in a round led by Indicator Capital
Neowrk, a startup that has developed advanced and unique hardware, software, and artificial intelligence technology to optimize workspace management, is receiving a R$ 10 million investment in a round led by Indicator Capital with R$ 8 million,...

at 17:31
Global Urine Output Monitoring Systems Market is Projected to Grow at a CAGR of ~5% by 2030 | DelveInsight
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:25
MEDIA ADVISORY - Ministers Wilkinson and Valdez to Highlight Budget 2024 Investments in Innovation and Productivity in Coquitlam
The Honourable Jonathan Wilkinson, Minister of Energy and Natural Resources, and the Honourable Rechie Valdez, Minister of Small Business, will hold a media availability to highlight the federal budget's commitments to getting projects built faster...

at 17:15
enosix, Inc. Opens New European Headquarters in Munich, Germany
enosix, Inc., the leading technology provider of real-time, prebuilt SAP process integration solutions, is thrilled to announce the opening of its EMEA Headquarters in Munich on April 25th. This strategic move reaffirms enosix's commitment to...

at 17:02
HAIVISION ANNOUNCES VOTING RESULTS FROM 2024 ANNUAL MEETING OF SHAREHOLDERS
Haivision Systems Inc. ("Haivision" or the "Company") is pleased to announce the voting results from its annual meeting of shareholders held today in a virtual format....

More news about Science and technology...


News published on and distributed by: